{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "We randomized 401 patients (MVS alone=203; MVS+TA=198)."
      },
      "Participants": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Intervention": {
        "score": 2,
        "evidence": "MVS alone=203; MVS+TA=198"
      },
      "Objective": {
        "score": 1,
        "evidence": "Here, we analyze the timing, indications, and risk factors for these implantations."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "A PPM was implanted in 36 patients (9.6%; 95 CI 6.8%\u221213.0%) within 2 years of randomization"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "We randomized 401 patients (MVS alone=203; MVS+TA=198)."
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "A PPM was implanted in 36 patients (9.6%; 95 CI 6.8%\u221213.0%)"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "RR 5.08; 95% CI 2.16\u201311.94; p<0.001"
      },
      "Harms": {
        "score": 1,
        "evidence": "However, this benefit was counterbalanced by an increase in permanent pacemakers (PPM)."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 12,
    "max_score": 25
  },
  "model": "gpt-4o"
}